Evidence map

ArticleiScience2025

Patient-specific therapeutic benefit of MuSK agonist antibody ARGX-119 in MuSK myasthenia gravis passive transfer models.

Jamie L Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39898046